Chronic hepatitis C (CHC)

Active Ingredient: Ribavirin

Indication for Ribavirin

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Ribavirin is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) for paediatric patients (children 3 years of age and older and adolescents) not previously treated and without liver decompensation.

For this indication, competent medicine agencies globally authorize below treatments:

600-800 mg in 2 divided doses daily

Route of admnistration

Oral

Defined daily dose

600 - 800 mg

Dosage regimen

From 300 To 400 mg 2 time(s) per day every day

Detailed description

No data are available in children below 3 years of age.

Dosing of ribavirin for children and adolescent patients is determined by the patient body weight. For example, the body weight dosing used in conjunction with interferon alfa-2b or peginterferon alfa-2b is shown in the table. Please refer to the corresponding SmPC of medicinal products used in combination with ribavirin as some combination regimens do not adhere to the ribavirin dosing guidance provided in the following table.

Ribavirin dose based on body weight when used in combination with interferon alfa-2b or peginterferon alfa-2b in paediatric patients:

Patient weight (kg)Daily ribavirin doseNumber of 200 mg capsules
47-49600 mg3 capsulesa
50-65800 mg4 capsulesb
>65Refer to adult dose recommendations

a 1 morning, 2 evening
b 2 morning, 2 evening

Dosage considerations

It should be administered orally with food.

Active ingredient

Ribavirin

Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin in combination with other medicinal products exerts its effects against HCV is unknown.

Read more about Ribavirin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.